The mixed cluster with very small dollar amounts relative to market cap is routine and non-informative. Monitor for a regulatory catalyst (FDA action on ATEV product candidate) which drives HUMA's binary risk, not insider trading patterns. The director purchase is a small positive signal but overwhelmed by routine C-suite selling.
Price Chart
Executive Summary
Two C-suite insiders (CFO and Chief Medical Officer) sold ~$82K in open-market sales on 2026-05-18, while a director bought $10K on the same day. The cluster is mixed but dominated by selling in dollar terms. At just 0.045% of HUMA's $183M market cap, the total sale value is trivial and below the 0.1% threshold for materiality. The buy is offset by the sales and neither side warrants a directional read.
Key Financial Metrics
Key Facts
- CFO Dale A. Sander sold 45,887 shares open-market at ~$0.90, total $41,147
- CMO Shamik J. Parikh sold 45,887 shares open-market at ~$0.90, total $41,147
- Director Michael T. Constantino bought 11,000 shares open-market at $0.89, total $9,840
- Total insider sell value = $82,294, total buy value = $9,840, net selling direction
- Combined trade value ($92K) is ~0.05% of HUMA's $183M market cap — trivial
- Insider sales clustered on same date likely reflects shared post-blackout-window selling, not coordinated bearish view
Financial Impact
Total insider activity $92K — less than 0.05% of market cap, no material impact
Risk Factors
- Insider sales may signal lack of conviction at current price, but amounts are too small to infer bearish view
- HUMA's stock is driven by FDA / clinical pipeline outcomes, not insider activity at this scale
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-HUMA-1779309157244 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $0.4400 | awaiting T+60 | — | $0.4010 (−8.86%) |
Aug 19, 2026 9w ago | Press Release | $0.7349 | awaiting T+60 | — | $0.4010 (−45.43%) |
Aug 12, 2026 10w ago | 8-K | $0.6650 | awaiting T+60 | — | $0.4010 (−39.70%) |
Aug 12, 2026 10w ago | Press Release | $0.6650 | awaiting T+60 | — | $0.4010 (−39.70%) |
Aug 7, 2026 11w ago | Press Release | $0.7180 | awaiting T+60 | — | $0.4010 (−44.15%) |
Jun 12, 2026 19w ago | Institutional Cluster | $1.06 $0.5790 | ▼ −45.12% | ▼ −47.90% | $0.4010 (−61.99%) |
Jun 11, 2026 19w ago | 8-K | $1.06 $0.5790 | ▲ +45.12% | ▲ +47.90% | $0.4010 (+61.99%) |
Jun 10, 2026 19w ago | Press Release | $1.08 $0.5949 | ▲ +44.92% | ▲ +48.74% | $0.4010 (+62.87%) |
Jun 10, 2026 19w ago | Press Release | $1.08 $0.5949 | ▲ +44.92% | ▲ +48.74% | $0.4010 (+62.87%) |
Jun 10, 2026 19w ago | Press Release | $1.08 $0.5949 | ▼ −44.92% | ▼ −48.74% | $0.4010 (−62.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers